Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Oxford Immunotec Global PLC | ex_105242.htm |
| EX-31.1 - EXHIBIT 31.1 - Oxford Immunotec Global PLC | ex_105241.htm |
| EX-23.1 - EXHIBIT 23.1 - Oxford Immunotec Global PLC | ex_105620.htm |
| EX-21.1 - EXHIBIT 21.1 - Oxford Immunotec Global PLC | ex_105240.htm |
| EX-10.50 - EXHIBIT 10.50 - Oxford Immunotec Global PLC | ex_105244.htm |
| EX-10.44 - EXHIBIT 10.44 - Oxford Immunotec Global PLC | ex_105238.htm |
| EX-10.33 - EXHIBIT 10.33 - Oxford Immunotec Global PLC | ex_105237.htm |
| EX-10.21 - EXHIBIT 10.21 - Oxford Immunotec Global PLC | ex_104989.htm |
| EX-10.5 - EXHIBIT 10.5 - Oxford Immunotec Global PLC | ex_105822.htm |
| 10-K - FORM 10-K - Oxford Immunotec Global PLC | oxfd20171231_10k.htm |
Exhibit 32
CERTIFICATION
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Oxford Immunotec Global PLC, a company incorporated in England and Wales (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2017 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: February 27, 2018 |
|
/s/ Peter Wrighton-Smith, Ph.D. |
|
|
|
Peter Wrighton-Smith, Ph.D. |
|
Date: February 27, 2018 |
|
/s/ Richard M. Altieri |
|
|
|
Richard M. Altieri |
This certification is being furnished and not filed, and shall not be incorporated into any document for any purpose, under the Securities Exchange Act of 1934 or the Securities Act of 1933.